Presentation
5 March 2021 Whole body fluorescence lifetime multiplexing of tumor receptor expression
Author Affiliations +
Abstract
Fluorescence imaging of cancers using continuous wave (CW) detection of receptor targeted probes offer poor sensitivity and specificity due to background autofluorescence and non-specific probe accumulation. Here we show that fluorescence lifetime (FLT) imaging can significantly improve tumor contrast using epidermal growth factor receptor (EGFR) and programed death ligand 1 (PD-L1) targeted probes in a preclinical model of human breast cancer. Our results suggest that these probes have significantly longer FLTs in tumors than in normal tissue and the FLT enhancement is receptor dependent. We also show potential for simultaneous quantification of EGFR and PD-L1 using in vivo FLT multiplexing.
Conference Presentation
© (2021) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Rahul Pal, Homan Kang, Hak Soo Choi, Gabriel D. Duda, and Anand T. N. Kumar "Whole body fluorescence lifetime multiplexing of tumor receptor expression", Proc. SPIE 11624, Visualizing and Quantifying Drug Distribution in Tissue V, 1162408 (5 March 2021); https://doi.org/10.1117/12.2578412
Advertisement
Advertisement
KEYWORDS
Tumors

Luminescence

Receptors

Multiplexing

In vivo imaging

Continuous wave operation

Signal detection

Back to Top